Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
View Older Stories View More Recent Stories
-
Piper Jaffray Hosts 23rd Annual Healthcare Conference
-
CryoLife to Present at 23rd Annual Piper Jaffray Health Care Conference
-
Notable Analyst Rating Changes 11/21: (WDC) (MS) (HOTT) Upgraded; (RIMM) (TGT) (WAG) Downgraded
-
Goldman Small Cap Research Initiates Coverage of Ecotech Energy Group, Inc.
-
Omthera Pharmaceuticals, Inc. to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
Piper Jaffray Upgrades Hot Topic (HOTT) to Overweight
-
Endologix to Present at Three Upcoming Investor Conferences
-
InSite Vision to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
Piper Jaffray Assumes Coverage on Green Dot (GDOT) at Neutral
-
Piper Jaffray Assumes Coverage on Euronet Worldwide (EEFT) at Overweight
-
Tengion to Present at Piper Jaffray 23rd Annual Health Care Conference
-
Myriad Genetics to Attend the 23rd Annual Piper Jaffray Health Care Conference
-
Concert Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Health Care Conference on November 30, 2011
-
ArthroCare Announces Participation in Investor Conference
-
Achillion to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
Zogenix to Present at Two Upcoming Conferences
-
BioDelivery Sciences to Present at the 23rd Annual Piper Jaffray Healthcare Conference
-
Quidel to Present at 23rd Annual Piper Jaffray Health Care Conference
-
Symmetry Medical to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
Orthofix International to Participate in the 23rd Annual Piper Jaffray Healthcare Conference
-
VCA Antech, Inc. to Speak at the Piper Jaffray 23rd Annual Healthcare Conference
-
MoneyGram International Announces Pricing of Secondary Offering
-
Boston Scientific to Participate in 2011 Piper Jaffray 23rd Annual Healthcare Conference
-
Incyte to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
St. Jude Medical to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
Baxter to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
Healthways to Present at the Piper Jaffray 23rd Annual Health Care Conference
-
Array BioPharma to Present at the Piper Jaffray Health Care Conference
-
Morning Movers 11/17: (ZOLL) (RMBS) (ABD) (PLCE) Higher; (PERY) (YOKU) (CIS) Lower
-
KBW Strengthens Diversified Financials Investment Banking Team
-
TranS1 Inc. to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
-
Hill-Rom to Participate in the Piper Jaffray Health Care Conference
-
MAKO Surgical Corp. to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
Piper Jaffray Downgrades DG FastChannel (DGIT) to Underweight
-
Piper Jaffray Upgrades Hollysys Automation Technologies (HOLI) to Overweight
-
Piper Jaffray Downgrades The Fresh Market (TFM) to Neutral
-
Piper Jaffray Starts NxStage Medical (NXTM) at Overweight
-
POZEN to Present at the Piper Jaffray 23rd Annual Healthcare Conference
-
Natus to Present at 23rd Annual Piper Jaffray Health Care Conference
-
ICU Medical, Inc. to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
Cyberonics to Present at 23rd Annual Piper Jaffray Health Care Conference
-
YuMe Secures Strategic $12 Million Investment from Samsung Ventures and Translink Capital
-
DynaVox to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
Pacira Pharmaceuticals, Inc. Announces Pricing of Follow-On Offering
-
Form 4 PIPER JAFFRAY COMPANIES For: Nov 15 Filed by: O'Brien Brien M
-
Wright Medical Group, Inc. to Participate in the 23rd Annual Piper Jaffray Healthcare Conference
-
XenoPort to Present at the 23rd Annual Piper Jaffray Health Care Conference
-
Ardea Biosciences to Present at Upcoming Investor Conferences
-
Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
-
Cutera to Present at the 23rd Annual Piper Jaffray Health Care Conference
